Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus - Bae, Jaehyun; Park, Taegyun; Kim, Hyeyoung; Lee, Minyoung; Cha, Bong-Soo (Diabetes & metabolism journal, 2021)
Keywords: Adipocytes; Atherosclerosis; Bladder cancer; Clinical significance; Cytochrome; Diabetes; diabetes mellitus, type 2; Diabetes Mellitus, Type 2 - drug therapy; Drug dosages; FDA approval; Humans; Hypoglycemic Agents - adverse effects; Insulin resistance; Kinases; Lipids; lobeglitazone; Males; Metabolism; Metabolites; Pharmacokinetics; Plasma; Pyrimidines; Review; thiazolidinediones; Thiazolidinediones - adverse effects; 내과학; Diabetes mellitus, type 2; Lobeglitazone; Thiazolidinediones